Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
Under the Spotlight: Agentic AI
In an interview with Pharmaceutical Outsourcing, ArisGlobal’s Jason Bryant discusses the premise of AI’s next high-profile incarnation, the technology’s potential in late-stage pharma R&D operations, emerging early use cases, and some of the guardrails that need to be in place to ensure trusted, impactful use. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Clinilabs Names Dagher CMO, Siddiqui Principal Investigator
Wednesday, August 05, 2026
Clinilabs has appointed Bob Dagher, M.D., as chief medical officer and Waqar Ahmed Siddiqui, M.D., as principal investigator at its Eatontown, New ... read more
Porton Advanced Wins Class C License to Expand CGT Manufacturing Into Commercial Stage
Wednesday, August 05, 2026
Porton Advanced Solutions has secured a Drug Manufacturing License (Class C) from China’s National Medical Products Administration, a milestone that ... read more
Altruist Biologics Completes First Commercial PPQ at Hangzhou Site
Wednesday, August 05, 2026
Altruist Biologics has completed the first commercial process performance qualification campaign for its 20,000L stainless steel bioreactors at its ... read more
Piramal Pharma Solutions Expands Turbhe Peptide Facility With New Spray Drying Suite
Tuesday, August 04, 2026
Piramal Pharma Solutions has expanded its peptide API facility in Turbhe, India, with a new spray drying suite designed to support challenging ... read more
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
Monday, August 03, 2026
Polpharma Biologics announced that the FDA and the EMA have accepted for review the Biologics License Application (BLA) and Marketing Authorization ... read more